WAM
AZN icon

Wealthspire Advisors (Maryland)’s AstraZeneca AZN Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$274K Sell
2,502
-4,883
-66% -$543K 0.01% 360
2020
Q2 		$781K Sell
7,385
-952
-11% -$98.3K 0.06% 192
2020
Q1 		$745K Sell
8,337
-1,307
-14% -$123K 0.06% 181
2019
Q4 		$962K Buy
9,644
+459
+5% +$43.2K 0.06% 180
2019
Q3 		$819K Sell
9,185
-35
-0.4% -$3.04K 0.06% 172
2019
Q2 		$761K Sell
9,220
-226
-2% -$17.7K 0.06% 179
2019
Q1 		$764K Sell
9,446
-1,468
-13% -$116K 0.06% 172
2018
Q4 		$829K Sell
10,914
-1,980
-15% -$155K 0.07% 141
2018
Q3 		$1.02M Buy
12,894
+208
+2% +$15.7K 0.08% 135
2018
Q2 		$891K Buy
12,686
+62
+0.5% +$4.46K 0.08% 138
2018
Q1 		$883K Sell
12,624
-528
-4% -$36.6K 0.08% 145
2017
Q4 		$913K Buy
13,152
+10,719
+441% +$723K 0.09% 145
2017
Q3 		$165K Buy
2,433
+307
+14% +$19.4K 0.02% 542
2017
Q2 		$145K Buy
2,126
+884
+71% +$57.7K 0.02% 556
2017
Q1 		$77K Buy
1,242
+604
+95% +$35.2K 0.01% 675
2016
Q4 		$35K Buy
638
+231
+57% +$13.1K 0.01% 859
2016
Q3 		$27K Hold
407
– – ﹤0.01% 966
2016
Q2 		$25K Buy
407
+35
+9% +$2.03K ﹤0.01% 919
2016
Q1 		$21K Sell
372
-30
-7% -$1.8K ﹤0.01% 952
2015
Q4 		$27K Buy
+402
New +$26.4K 0.01% 876

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s AZN Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its AstraZeneca (AZN) stake by 66% in Q3 2020, selling an estimated $543K and leaving 2,502 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #360.

Wealthspire Advisors (Maryland) first reported a position in AZN in Q4 2015 and has held it in 20 quarters since. The position peaked at $1.02M in Q3 2018. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 2,502 shares of AstraZeneca worth $274K as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 4,883 AstraZeneca shares in Q3 2020, an estimated $543K.
  • AstraZeneca made up 0.01% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #360 holding.
  • Wealthspire Advisors (Maryland) first reported a position in AstraZeneca in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s AstraZeneca position peaked at $1.02M in Q3 2018.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.